Adipose tissue as a living drug: Stromal vascular fraction and adipose tissue-derived stem cells in regenerative medicine

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 12

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Dec 26, 2025; 17(12): 114170
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.114170

Full Size Figure Download Figure

Figure 1 Historical background of adipose tissue use in therapy. SVF: Stromal vascular fraction; ASCs: Adipose-derived stem cells.

Citation: Choudhery MS, Niaz A, Arif T, Mahmood R. Adipose tissue as a living drug: Stromal vascular fraction and adipose tissue-derived stem cells in regenerative medicine. World J Stem Cells 2025; 17(12): 114170
URL: https://www.wjgnet.com/1948-0210/full/v17/i12/114170.htm
DOI: https://dx.doi.org/10.4252/wjsc.v17.i12.114170

Choudhery MS, Niaz A, Arif T, Mahmood R. Adipose tissue as a living drug: Stromal vascular fraction and adipose tissue-derived stem cells in regenerative medicine. World J Stem Cells 2025; 17(12): 114170 [PMID: 41480399 DOI: 10.4252/wjsc.v17.i12.114170]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.